ArticleFrontiers in immunology2022

Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.

Yun Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.